JPRN-UMIN000017104已完成未知
Personalized therapy for methotrexate in patients with rheumatoid arthritis - Personalized therapy for methotrexate
Faculty of Pharmacy, Keio Univeristy Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 300 人开始时间: 2015年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Nothing special defined
研究者
相似试验
招募中
不适用
Precision medicine of methotrexate in the patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000027250Keio University Fukuoka Tokushukai Hospital50
尚未招募
不适用
Treatment with high dose Methotrexate in patients with generalized eosinophilic fasciitisShulman's syndrome or diffuse fasciitis10010761NL-OMON30014niversitair Medisch Centrum Sint Radboud6
进行中（未招募）
不适用
Treatment with high dose Methotrexate in patients with eosinophilic fasciitis - High dose Methotrexate in eosinophilic fasciitisEosinophilic fasciitis (EF) is a skin disorder involving the deep fascia, resulting in pain and swelling of extremities, cutaneous induration and joint contractures. Most patients require therapy. No controlled trials have been reported. we treated EF patients with intramuscular Methotrexate (MTX)1 mg/kg weekly. In general, the results were not satisfactory and side-effects frequent. With high dose intravenous MTX4 mg/kg every four weeks, we expect a better effect with less side effects.EUCTR2006-003123-37-NLniversity Hospital Sint Radboud
已完成
2 期
Study of methotrexate for the control of chronic inflammation in sickle cell disease patientsPatients with Sickle cell diseaseD57.0RBR-2s9xvnCentro Infantil Boldrini
已完成
不适用
Effects of Methotrexate on oral lichen planuslichen planus.Other lichen planusIRCT2013121715655N2Tehran University Of Medical Sciences15